Author:
Jiménez-Fonseca P., ,Carmona-Bayonas A.,Martín-Pérez E.,Crespo G.,Serrano R.,Llanos M.,Villabona C.,García-Carbonero R.,Aller J.,Capdevila J.,Grande E.
Publisher
Springer Science and Business Media LLC
Reference149 articles.
1. Yao, J. C., Hassan, M., Phan, A., et al. (2008). One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the united states. Journal of Clinical Oncology, 26(18), 3063–3072.
2. Beaumont, J. L., Cella, D., Phan, A. T., Choi, S., Liu, Z., & Yao, J. C. (2012). Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population. Pancreas, 41(3), 461–466.
3. Larsson, G., Sjoden, P. O., Oberg, K., Eriksson, B., & von Essen, L. (2001). Health-related quality of life, anxiety and depression in patients with midgut carcinoid tumours. Acta Oncologica, 40(7), 825–831.
4. US Department of Health and Human Services. (2006). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health and Quality of Life Outcomes, 4, 79.
5. Redeker, N. S., Lev, E. L., & Ruggiero, J. (2000). Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Scholarly Inquiry for Nursing Practice, 14(4), 275–290. discussion 291–8.
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献